Novelta exhibits higher acid neutralizing capacity than conventional antacid

According to guideline of USFDA an antacid must have a Acid Neutralizing capacity > 5 mEq (milliequivalent) and an effective antacid must have higher and prolonged acid neutralization capacity. Orion Pharma Ltd. Introduces 1^st time in Bangladesh- Novelta, A novel antacid. A comparative study was performed to compare the acid neutralizing capacity of all the available antacids. Among them, Magaldrate and Simethicone combination (Novelta) has the higher acid neutralizing capacity.

A novel antacid to treat Hyperacidity, Heartburn, Gastric & Duodenal Ulcer, Dyspepsia, GERD & Flatulence

Indications Hyperacidity, Gastric & Duodenal ulcer, Gastritis, Heartburn, Dyspepsia, Gastroesophageal reflux. Also indicated for the relief of Flatulence, Abdominal distention and Windy colic.

Dosage and Administration 2-4 teaspoonful (10-20 ml) or1-4 tablets of Novelta chewable tablet, 20 minutes to 1 hour after meals and at bedtime, or as directed by physician.

Available as: Novelta Suspension 100 ml Novelta Suspension 200 ml Novelta Chewable Tablet."

Why Chewable Antacid is Better in heartburn?

Chewable antacid is more effective in preventing heartburn than swallowing an antacid, because antacids are primarily active in esophageal lumen, rather than neutralization of intragastric contents. When a tablet is swallowed it passes through the stomach too fast to neutralize the acid and when a tablet chewed, the antacid is ready to work as soon as it reaches the stomach.